• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍奇金淋巴瘤细胞系的特征是2号染色体和9号染色体频繁出现畸变,包括REL和JAK2基因。

Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

作者信息

Joos Stefan, Granzow Martin, Holtgreve-Grez Heidi, Siebert Reiner, Harder Lana, Martín-Subero José I, Wolf Jürgen, Adamowicz Martyna, Barth Thomas F E, Lichter Peter, Jauch Anna

机构信息

German Cancer Research Center, H0700, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.

出版信息

Int J Cancer. 2003 Feb 10;103(4):489-95. doi: 10.1002/ijc.10845.

DOI:10.1002/ijc.10845
PMID:12478664
Abstract

Four Hodgkin's lymphoma cell lines (KM-H2, HDLM-2, L428, L1236) were analyzed for cytogenetic aberrations, applying multiplex fluorescence in situ hybridization, chromosome banding and comparative genomic hybridization. Each line was characterized by a highly heterogeneous pattern of karyotypic changes with a large spectrum of different translocated chromosomes (range 22-57). A recurrent finding in all cell lines was the presence of chromosomal rearrangements of the short arm of chromosome 2 involving the REL oncogene locus. Furthermore, multiple translocated copies of telomeric chromosomal segments were frequently detected. This resulted in a copy number increase of putative oncogenes, e.g., JAK2 (9p24) in 3 cell lines, FGFR3 (4p16) and CCND2 (12p13) in 2 cell lines as well as MYC (8q24) in 1 cell line. Our data confirm previous cytogenetic results from primary Hodgkin's tumors suggesting an important pathogenic role of REL and JAK2 in this disease. In addition, they provide evidence for a novel cytogenetic pathomechanism leading to increased copy numbers of putative oncogenes from terminal chromosomal regions, most probably in the course of chromosomal stabilization by telomeric capture.

摘要

应用多重荧光原位杂交、染色体显带和比较基因组杂交技术,对4种霍奇金淋巴瘤细胞系(KM-H2、HDLM-2、L428、L1236)进行细胞遗传学畸变分析。每个细胞系的核型变化模式高度异质性,存在大量不同的易位染色体(范围为22 - 57条)。所有细胞系中反复出现的一个现象是,2号染色体短臂发生涉及REL癌基因位点的染色体重排。此外,还经常检测到端粒染色体片段的多个易位拷贝。这导致了假定癌基因的拷贝数增加,例如,3个细胞系中JAK2(9p24)、2个细胞系中FGFR3(4p16)和CCND2(12p13)以及1个细胞系中MYC(8q24)。我们的数据证实了先前原发性霍奇金肿瘤的细胞遗传学结果,表明REL和JAK2在该疾病中具有重要的致病作用。此外,它们还为一种新的细胞遗传学发病机制提供了证据,该机制导致来自染色体末端区域的假定癌基因拷贝数增加,很可能是在通过端粒捕获实现染色体稳定的过程中发生的。

相似文献

1
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.霍奇金淋巴瘤细胞系的特征是2号染色体和9号染色体频繁出现畸变,包括REL和JAK2基因。
Int J Cancer. 2003 Feb 10;103(4):489-95. doi: 10.1002/ijc.10845.
2
Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.基因组失衡,包括CD30+霍奇金细胞中酪氨酸激酶基因JAK2的扩增。
Cancer Res. 2000 Feb 1;60(3):549-52.
3
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.涉及REL基因座的2号染色体短臂增益与经典型霍奇金淋巴瘤肿瘤细胞中的核c-Rel蛋白积累相关。
Blood. 2003 May 1;101(9):3681-6. doi: 10.1182/blood-2002-08-2577. Epub 2003 Jan 2.
4
Alterations at the rel locus in human lymphoma.人类淋巴瘤中rel基因座的改变。
Oncogene. 1991 Jul;6(7):1235-41.
5
Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene.原发性纵隔(胸腺)B细胞淋巴瘤的特征是染色体物质增加,包括9p以及REL基因扩增。
Blood. 1996 Feb 15;87(4):1571-8.
6
Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.宫颈癌细胞系的全面分子细胞遗传学特征分析
Genes Chromosomes Cancer. 2003 Mar;36(3):233-41. doi: 10.1002/gcc.10158.
7
Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.对一组伯基特淋巴瘤来源的B细胞系进行联合光谱核型分析、比较基因组杂交和体外凋亡分析,揭示了染色体畸变的意外复杂性以及化疗耐药细胞系中特定异常的复发情况。
Int J Oncol. 2006 Mar;28(3):605-17.
8
Centromeric instability of chromosome 1 resulting in multibranched chromosomes, telomeric fusions, and "jumping translocations" of 1q in a human immunodeficiency virus-related non-Hodgkin's lymphoma.在人类免疫缺陷病毒相关的非霍奇金淋巴瘤中,1号染色体的着丝粒不稳定导致多分支染色体、端粒融合以及1q的“跳跃易位”。
Cancer. 1995 Oct 1;76(7):1238-44. doi: 10.1002/1097-0142(19951001)76:7<1238::aid-cncr2820760722>3.0.co;2-8.
9
Genomic alterations in Hodgkin's lymphoma.霍奇金淋巴瘤中的基因组改变。
Int J Hematol. 2006 Jun;83(5):379-84. doi: 10.1532/IJH97.06048.
10
Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?节段性染色体畸变和中心体扩增:经典型霍奇金淋巴瘤中霍奇金和里德-斯腾伯格细胞的致病机制?
Leukemia. 2003 Nov;17(11):2214-9. doi: 10.1038/sj.leu.2403129.

引用本文的文献

1
Histopathologic Features and Differential Diagnosis in Challenging Cases of Nodular Lymphocyte Predominant B-cell Lymphoma/Nodular Lymphocyte Predominant Hodgkin Lymphoma.结节性淋巴细胞为主型B细胞淋巴瘤/结节性淋巴细胞为主型霍奇金淋巴瘤疑难病例的组织病理学特征及鉴别诊断
J Clin Transl Pathol. 2024 Jun;4(2):61-69. doi: 10.14218/jctp.2024.00015.
2
Advances in the treatment of Hodgkin's lymphoma (Review).霍奇金淋巴瘤治疗的进展(综述)。
Int J Oncol. 2023 May;62(5). doi: 10.3892/ijo.2023.5509. Epub 2023 Apr 7.
3
[Classification of Hodgkin lymphoma and related entities : News and open questions].
[霍奇金淋巴瘤及相关实体的分类:新进展与未解决的问题]
Pathologie (Heidelb). 2023 May;44(3):184-192. doi: 10.1007/s00292-023-01188-3. Epub 2023 Mar 17.
4
Cohesin depleted cells rebuild functional nuclear compartments after endomitosis.黏合蛋白耗竭的细胞在有丝分裂后重建功能性核区室。
Nat Commun. 2020 Dec 1;11(1):6146. doi: 10.1038/s41467-020-19876-6.
5
Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma.肿瘤微环境中的免疫和炎症细胞是经典霍奇金淋巴瘤的新治疗靶点。
Int J Mol Sci. 2019 Nov 5;20(21):5503. doi: 10.3390/ijms20215503.
6
The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma.帕博利珠单抗在复发/难治性原发性纵隔大B细胞淋巴瘤中的作用。
Ther Adv Hematol. 2019 Apr 22;10:2040620719841591. doi: 10.1177/2040620719841591. eCollection 2019.
7
Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma.爱泼斯坦-巴尔病毒编码的潜伏膜蛋白的共表达与经典型霍奇金淋巴瘤的发病机制
Cancers (Basel). 2018 Aug 24;10(9):285. doi: 10.3390/cancers10090285.
8
Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma.爱泼斯坦-巴尔病毒潜伏蛋白在经典型霍奇金淋巴瘤发病机制中的作用
Pathogens. 2018 Jun 27;7(3):59. doi: 10.3390/pathogens7030059.
9
Ruxolitinib significantly enhances apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model.芦可替尼显著增强霍奇金淋巴瘤和原发性纵隔B细胞淋巴瘤中的细胞凋亡,并延长淋巴瘤异种移植小鼠模型的生存期。
Oncotarget. 2018 Jan 18;9(11):9776-9788. doi: 10.18632/oncotarget.24267. eCollection 2018 Feb 9.
10
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.一项评估口服 JAK1/JAK2 抑制剂芦可替尼治疗晚期复发/难治性霍奇金淋巴瘤的 II 期研究。
Haematologica. 2018 May;103(5):840-848. doi: 10.3324/haematol.2017.180554. Epub 2018 Jan 19.